MedPath

PROHIBIT INJ VACCINE

PROHIBIT INJ VACCINE

Discontinued
DIN Number

00764221

Drug Class

Human

Market Date

Dec 31, 1988

Company
HC

aventis pasteur limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00764221
AIG Number0219892001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07AG51 HEMOPHILUS INFLUENZAE B, COMBINATIONS WITH TOXOIDS
Product Specifications
Dosage FormLiquid
Route of AdministrationIntramuscular
AHFS Classification80:12.00
Health Canada Classification

ACTIVE INGREDIENTS (2)

DIPHTHERIA TOXOIDActive
Strength: 23 MCG / 0.5 ML
Monograph: DIPHTHERIA TOXOID
HAEMOPHILUS INFLUENZAE TYPE B-PRPActive
Strength: 25 MCG / 0.5 ML
Monograph: HAEMOPHILUS INFLUENZAE TYPE B-PRP

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.